Form DEF 14A Fortress Biotech, Inc. For: May 23 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Cyprium Therapeutics, a Fortress Biotech Subsidiary globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
Sentynl Therapeutics Completes Asset Transfer of CUTX-101 from Cyprium Therapeutics equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.
U.S. FDA nod for Zydus Lifesciences' generic injection thehindu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindu.com Daily Mail and Mail on Sunday newspapers.
Fortress expects to file a total of three new drug applications in 2023 Record consolidated net revenue of $75.7 million for full-year 2022 FDA accepted...
Fortress expects to file a total of three new drug applications in 2023 Record consolidated net revenue of $75.7 million for full-year 2022 FDA accepted for filing the Biologics License Application... | March 30, 2023
EQS-News: Fortress Biotech, Inc. Fortress Bio’s Portfolio Of Marketed Drugs Could Soon See Three Additions 06.10.2022 / 14:00 CET/CEST The issuer is solely responsible for the content of this announcement. Fortress Biotech Inc. (NASDAQ: FBIO) is a biopharmaceutical company focused on developing ...
Net revenue for the first half of 2022 increased 45.5% period-over-period to $42.8 million Positive results from registration-enabling study of cosibelimab in metastatic cutaneous squamous cell... | August 11, 2022
The data will be presented as a “Top-Rated Abstract” and Poster at the 2022 American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting taking place March 22-26, 2022.